Shanghai ComGen Biopharmaceutical

Shanghai ComGen Biopharmaceutical is a clinical-stage biotechnology company headquartered in the Zhangjiang Hi-Tech Park of Shanghai, China. The company specializes in the research, development, and large-scale manufacturing of therapeutic biologics, with a primary focus on monoclonal antibodies and recombinant proteins. Its pipeline is heavily weighted toward high-quality biosimilars and biobetters targeting oncology, autoimmune diseases, and metabolic disorders. ComGen leverages a proprietary mammalian cell culture and protein purification platform to advance its candidates through the clinical regulatory process. The company aims to provide cost-effective biopharmaceutical solutions to address significant unmet medical needs in the Chinese and global markets.